DA
Derek Archila Wells Fargo Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
75
Avg Return
Past Year
Past Year
16%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
78.9%
Neutral
21.1%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Energy
Healthcare
Energy
Oil & Gas Midstream
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $143 |
61%
upside
| 3 | +18% |
0
%
| 12 Mar ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $48 |
84%
upside
| 1 | +19% |
0
%
| 3 Mar ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $79 |
10%
upside
| 3 | -9.6% |
0
%
| 2 Mar ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $1,247 |
47%
upside
| 3 | +5.2% |
0
%
| 27 Feb ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $110 |
108%
upside
| 2 | -15% |
0
%
| 27 Feb ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $98 |
28%
upside
| 2 | +4.8% |
0
%
| 13 Feb ‘26 2 months ago |
|
|
|
Equal-Weight
Maintained
| $101 |
3%
upside
| 2 | +11% |
0
%
| 11 Feb ‘26 2 months ago |
|
|
|
Equal-Weight
Maintained
| $29 |
96%
upside
| 1 | – |
–
| 3 Feb ‘26 2 months ago |
|
|
|
Overweight
Maintained
| $29 |
66%
upside
| 2 | +18% |
0
%
| 29 Jan ‘26 2 months ago |
|
|
|
Overweight
Maintained
| $330 |
35%
upside
| 2 | +6.7% |
0
%
| 20 Jan ‘26 2 months ago |
|
|
|
Overweight
Maintained
| $26 |
36%
downside
| 1 | -9.4% |
0
%
| 20 Jan ‘26 2 months ago |
|
|
|
Equal-Weight
Maintained
| $376 |
21%
upside
| 1 | – |
–
| 20 Jan ‘26 2 months ago |
|